Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
Craythorne, Emma
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. [electronic resource] - Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology Sep 2011 - 616-20 p. digital
Publication Type: Journal Article
1600-0714
10.1111/j.1600-0714.2011.01017.x doi
Adjuvants, Immunologic--therapeutic use
Adrenal Cortex Hormones--therapeutic use
Aged
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antigens, CD20
Drug Administration Schedule
Drug Resistance
Female
Follow-Up Studies
Humans
Immunologic Factors--administration & dosage
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Mouth Diseases--complications
Pemphigus--complications
Rituximab
Severity of Illness Index
Skin Diseases--complications
Treatment Outcome
Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. [electronic resource] - Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology Sep 2011 - 616-20 p. digital
Publication Type: Journal Article
1600-0714
10.1111/j.1600-0714.2011.01017.x doi
Adjuvants, Immunologic--therapeutic use
Adrenal Cortex Hormones--therapeutic use
Aged
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antigens, CD20
Drug Administration Schedule
Drug Resistance
Female
Follow-Up Studies
Humans
Immunologic Factors--administration & dosage
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Mouth Diseases--complications
Pemphigus--complications
Rituximab
Severity of Illness Index
Skin Diseases--complications
Treatment Outcome